Active Removal of IntraCerebral Hematoma Via Active Irrigation
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorIRRAS
About this trial
Study evaluating if active irrigation by IRRAflow® with infusion of tPA will reduce the time needed for clearance of intracerebral and intraventricular hemorrhage compared with passive drainage.
Eligibility criteria
Qualifiers
Age >18 years of age
Need of EVD
Active treatment
Signed informed consent obtained
Disqualifiers
Age < 18 years
No need of EVD
Patient has fixed and dilated pupils
Coagulopathy uncorrectable
Trial design
Treatments tested in this trial
- IRRAflow
- EVD
Treatment groups
60 Participants
are divided into 3 treatment groupsSponsors and collaborators
IRRAS
Lead sponsor
University of Helsinki
Collaborator
Northwestern University
Collaborator
West Virginia University
Collaborator
Klinikum Bergmannstrost
Collaborator
Stony Brook University Hospital
Collaborator
Icahn School of Medicine at Mount Sinai
Collaborator
Buffalo General Medical Center
Collaborator
Source ClinicalTrials.gov